Liqin Ping
Overview
Explore the profile of Liqin Ping including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang C, Li Y, He H, Gao Y, Zhang X, Bai B, et al.
Ann Hematol
. 2025 Feb;
PMID: 39934426
The aim of this study was to investigate the prognostic value of baseline PET/CT parameters alone and combined with clinical features in Extranodal Natural killer/T-cell lymphoma (ENKTL) patients treated with...
2.
Gao Y, Ping L, Shan C, Huang H, Li Z, Zhou H, et al.
Blood Cancer Discov
. 2025 Feb;
PMID: 39913173
Genetic alterations of chronic active B-cell receptor signaling often occur in primary central nervous system lymphoma (PCNSL). We conducted a phase-II trial of high-dose methotrexate plus ibrutinib and temozolomide (MIT)...
3.
Gao Y, He H, Li X, Zhang L, Xu W, Feng R, et al.
Signal Transduct Target Ther
. 2024 May;
9(1):121.
PMID: 38755119
Anti-PD-1 antibodies are a favorable treatment for relapsed or refractory extranodal natural killer T cell lymphoma (RR-ENKTL), however, the complete response (CR) rate and the duration of response (DOR) need...
4.
Zhong Y, Xie J, Chen J, Ping L, Zang S, Zhang Y, et al.
Am J Surg Pathol
. 2023 Nov;
48(2):174-182.
PMID: 37982454
Extranodal NK/T-cell lymphoma (ENKTL) is a non-Hodgkin lymphoma associated with the Epstein-Barr virus that primarily affects individuals in East Asia and indigenous populations in Central and South America. Morphologically, ENKTL...
5.
Ping L, Gao Y, He Y, Bai B, Huang C, Shi L, et al.
Ann Hematol
. 2023 Jun;
102(8):2189-2198.
PMID: 37306710
The prognosis of relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) is poor. The efficacy of salvage therapy with ICE (ifosfamide, carboplatin, and etoposide) is limited. DLBCL can evade immune surveillance...
6.
Ping L, He Y, Gao Y, Wang X, Huang C, Bai B, et al.
J Pers Med
. 2022 Dec;
12(11).
PMID: 36579538
Background: Diffuse large B-cell lymphoma (DLBCL) is the most prevalent type of lymphoma that is potentially curable by chemotherapy. Immunogenic cell death (ICD) is regarded as an essential process for...
7.
Ping L, Gao Y, He Y, Wang X, Bai B, Huang C, et al.
Oxid Med Cell Longev
. 2022 Aug;
2022:2679154.
PMID: 35965687
Background: T lymphoblastic lymphoma/leukemia (T-LBL/ALL) is an aggressive malignant tumor with 5-year overall survival (OS) rate reached 80% after high-dose chemotherapy. Due to the relatively low incidence of T-LBL/ALL, only...
8.
He Y, Gao Y, Ping L, He H, Huang C, Bai B, et al.
J Cancer Res Clin Oncol
. 2022 Jul;
149(5):2017-2027.
PMID: 35809114
Purpose: Anti-PD-1 antibody (anti-PD-1 mAb) showed favorable outcomes in some patients with relapsed/refractory (r/r) extranodal NK/T-cell lymphoma (ENKTL). However, the role of anti-PD-1 antibody in NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis (NK/T-LAHS)...
9.
Zhang K, Ping L, Du T, Wang Y, Sun Y, Liang G, et al.
Oxid Med Cell Longev
. 2021 Oct;
2021:9441896.
PMID: 34659642
Background: Breast cancer was associated with imbalance between oxidation and antioxidation. Local oxidative stress in tumors is closely related to the occurrence and development of breast cancer. However, the relationship...
10.
Ping L, Zhang K, Ou X, Qiu X, Xiao X
Front Cell Dev Biol
. 2021 Oct;
9:727183.
PMID: 34616734
Pyroptosis, a kind of programmed cell death characterized by the rupture of cell membranes and the release of inflammatory substances, plays an important role in the occurrence and development of...